Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma

NCT02342782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: Yttrium Y 90 Basiliximab
DRUG: Carmustine
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Melphalan
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study

Sponsor

City of Hope Medical Center

Collaborators

[object Object]